High levels of metastasis-inducing S100A4 protein and treatment outcome in early rheumatoid arthritis: data from the PERAC cohort

References

• Aletaha D, Neogi T, Silman AJ, et al. (2010). 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 69:1580–8
   PubMed Web of Science ®Google Scholar
• Andrés Cerezo L, Mann H, Pecha O, et al. (2011). Decreases in serum levels of S100A8/9 (calprotectin) correlate with improvements in total swollen joint count in patients with recent-onset rheumatoid arthritis. Arthritis Res Ther 26;13:R122
   Web of Science ®Google Scholar
• Cerezo LA, Kuncová K, Mann H, et al. (2011). The metastasis promoting protein S100A4 is increased in idiopathic inflammatory myopathies. Rheumatology (Oxford) 50:1766–72
   PubMed Web of Science ®Google Scholar
• Cerezo LA, Remáková M, Tomčik M, et al. (2014). The metastasis-associated protein S100A4 promotes the inflammatory response of mononuclear cells via the TLR4 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 53:1520–6
   PubMed Web of Science ®Google Scholar
• Dempsie Y, Nilsen M, White K, et al. (2011). Development of pulmonary arterial hypertension in mice over-expressing S100A4/Mts1 is specific to females. Respir Res 12:159
   PubMed Web of Science ®Google Scholar
• Erlandsson MC, Forslind K, Andersson SE, et al. (2012). Metastasin S100A4 is increased in proportion to radiographic damage in patients with RA. Rheumatology (Oxford) 51:932–40
   PubMed Web of Science ®Google Scholar
• Erlandsson MC, Svensson MD, Jonsson IM, et al. (2013). Expression of metastasin S100A4 is essential for bone resorption and regulates osteoclast function. Biochim Biophys Acta 1833:2653–63
   PubMed Web of Science ®Google Scholar
• Gremese E, Salaffi F, Bosello SL, et al. (2013). Very early rheumatoid arthritis as a predictor of remission: a multicentre real life prospective study. Ann Rheum Dis 72:858–62
   PubMed Web of Science ®Google Scholar
• Haraoui B, Smolen JS, Aletaha D, et al. (2011). Treating rheumatoid arthritis to target: multinational recommendations assessment questionnaire. Ann Rheum Dis 70:1999–2002
   PubMed Web of Science ®Google Scholar
• Helfman DM, Kim EJ, Lukanidin E, Grigorian M. (2005). The metastasis associated protein S100A4: role in tumour progression and metastasis. Br J Cancer 92:1955–8
   PubMed Web of Science ®Google Scholar
• Huang Y, Fernandez SV, Goodwin S, et al. (2007). Epithelial to mesenchymal transition in human breast epithelial cells transformed by 17beta-estradiol. Cancer Res 67:11147–57
   PubMed Web of Science ®Google Scholar
• Klingelhöfer J, Senolt L, Baslund B, et al. (2007). Up-regulation of metastasis-promoting S100A4 (Mts-1) in rheumatoid arthritis: putative involvement in the pathogenesis of rheumatoid arthritis. Arthritis Rheum 56:779–89
   PubMed Web of Science ®Google Scholar
• McInnes IB, O'Dell JR. (2010). State-of-the-art: rheumatoid arthritis. Ann Rheum Dis 69:1898–906
   PubMed Web of Science ®Google Scholar
• Oslejsková L, Grigorian M, Gay S, et al. (2008). The metastasis associated protein S100A4: a potential novel link to inflammation and consequent aggressive behaviour of rheumatoid arthritis synovial fibroblasts. Ann Rheum Dis 67:1499–504
   PubMed Web of Science ®Google Scholar
• Ošlejšková L, Grigorian M, Hulejová H, et al. (2009). Metastasis-inducing S100A4 protein is associated with the disease activity of rheumatoid arthritis. Rheumatology (Oxford) 48:1590–4
   PubMed Web of Science ®Google Scholar
• Saleem B, Nizam S, Emery P. (2006). Can remission be maintained with or without further drug therapy in rheumatoid arthritis? Clin Exp Rheumatol 24:S-33–6
   Web of Science ®Google Scholar
• Schipper LG, Fransen J, den Broeder AA, Van Riel PL. (2010). Time to achieve remission determines time to be in remission. Arthritis Res Ther 12:R97
   PubMed Web of Science ®Google Scholar
• Scott DL, Wolfe F, Huizinga TW. (2010). Rheumatoid arthritis. Lancet 376:1094–108
   PubMed Web of Science ®Google Scholar
• Smolen JS, Aletaha D, Bijlsma JW, et al. (2010). Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis 69:631–7
   PubMed Web of Science ®Google Scholar
• Senolt L, Grigorian M, Lukanidin E, et al. (2006). S100A4 is expressed at site of invasion in rheumatoid arthritis synovium and modulates production of matrix metalloproteinases. Ann Rheum Dis 65:1645–8
   PubMed Web of Science ®Google Scholar
• Senolt L, Vencovský J, Pavelka K, et al. (2009). Prospective new biological therapies for rheumatoid arthritis. Autoimmun Rev 9:102–7
   PubMed Web of Science ®Google Scholar
• Vermeer M, Kuper HH, Hoekstra M, et al. (2011). Implementation of a treat-to-target strategy in very early rheumatoid arthritis: results of the Dutch Rheumatoid Arthritis Monitoring remission induction cohort study. Arthritis Rheum 63:2865–72
   PubMed Web of Science ®Google Scholar
• Zibert JR, Skov L, Thyssen JP, et al. (2010). Significance of the S100A4 protein in psoriasis. J Invest Dermatol 130:150–60
   PubMed Web of Science ®Google Scholar